SCHEMBL19785362

SCHEMBL19785362

Clc1ccc(-c2ccccc2)cc1-c1cc(-c2ccccc2)ccc1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 2/20 0.56
CYP2A6 P11509 1/20 0.54
CYP1A2 P05177 2/20 0.52
MEN1 O00255 2/20 0.48
LMNA P02545 2/20 0.48
MAPT P10636 2/20 0.48
HTT P42858 2/20 0.48
KMT2A Q03164 2/20 0.48
APAF1 O14727 1/20 0.48
NPC1 O15118 1/20 0.48
THRB P10828 1/20 0.48
XBP1 P17861 1/20 0.48
PTBP1 P26599 1/20 0.48
RAB9A P51151 1/20 0.48
GALK1 P51570 1/20 0.48
BLM P54132 1/20 0.48
SMAD3 P84022 1/20 0.48
ATM Q13315 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20955807 0.93 CYP2A6 (0.58) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL22544432 0.93 CYP2A6 (0.58) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL29778098 0.93 CYP2A6 (0.58) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL29935106 0.93 CYP2A6 (0.58) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL24780966 0.89 CYP2A6 (0.54) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL28976272 0.89 CYP2A6 (0.54) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL6562990 0.87 CYP1A2 (0.62) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL28946481 0.86 ESR2 (0.58) ESR2CYP2A6CYP1A2MEN1LMNA
SCHEMBL28946479 0.83 MMP3 (0.58) ESR2CYP2A6MEN1KMT2AALOX5
SCHEMBL26805869 0.83 ALDH1A1 (0.58) ESR2CYP2A6CYP1A2MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10246415-B2 Process for preparing carbazoles DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-02 US disclosed
WO-2018013067-A1 PROCESS FOR PREPARING CARBAZOLES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246415-B2 Process for preparing carbazoles DCLK2, DCLK1, PDCD2L ESR2 3209/4885CYP2A6 1172/4885CYP1A2 255/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.